South Korea Chronic Obstructive Pulmonary Disease (COPD) Market
The South Korea Chronic Obstructive Pulmonary Disease (COPD) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Chronic Obstructive Pulmonary Disease (COPD) market. This report explores all the key factors affecting the growth of the global South Korea Chronic Obstructive Pulmonary Disease (COPD) market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.
Get PDF Sample Report Now! @ www.prudentmarkets.com/sample-request/141681/
Report Overview
The South Korea chronic obstructive pulmonary disease market size stood at around USD 10.5 millions in 2019 and is projected to reach xx millions by 2028, exhibiting a CAGR of around xx during the forecast period.
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease characterized by persistent respiratory symptoms such as cough, sputum, dyspnoea, and irreversible airway obstruction.COPD is known to be caused by smoking, occupational exposure, air pollution, etc and it is known that small airway lung disease and lung parenchymal destruction caused by this cause airflow restrictions and various clinical symptoms.
The prevalence of chronic obstructive pulmonary disease (COPD) in Korea between 2007 and 2015 was about 13%. COPD was the third leading cause of death in 2016 worldwide, claiming 3 million lives and ranked 8th in causes of death in Korea in 2018.
Market Drivers
The rise in the elderly population and increasing prevalence of COPD positively affect the market growth. COPD is caused by the interaction of personal factors such as lung growth disorder and genetic predisposition, behavioural factors such as smoking and environmental factors such as indoor air pollution and fine dust. According to a study by Kim Y et al; the prevalence of COPD in males was more among ex-smokers and current smokers than among non-smokers. There is a continuous increase in cases because of these factors, and this trend is expected to continue in the future.
To Know More About COVID-19 Impact On South Korea Chronic Obstructive Pulmonary Disease (COPD) Market @ www.prudentmarkets.com/sample-request/141681/
Market Segmentation
By Treatment type:
On the basis of treatment type, COPD market is majorly segmented into drugs, surgery, and oxygen therapy.
Drugs are further sub-segmented into bronchodilators monotherapy and anti-inflammatory drugs. Bronchodilators constitute short -acting beta -2 antagonist (SABAs), long -acting beta -2 antagonist (LABAs) and anti-cholinergic agents. Anti - inflammatory drugs include oral and inhaled corticosteroids and anti-leukotrienes. Surgery is further sub-segmented into lung volume reduction surgery, lung transplant, bullectomy and others.
Top Players
Some of the major players in market are AstraZeneca, GSK, Boehringer Ingelheim, Novartis, Daewoong Pharmaceuticals, Hanmi Pharmaceuticals, Kolon Pharmaceuticals, Youngjin Pharm. Seretide by GSK is one of the leading bronchodilators in the market followed by Spirivar by Boehringer Ingelheim. The companies are implementing innovative strategies that is helping them in strengthening their market position.
Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.
Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ www.prudentmarkets.com/discount-request/141681/
The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global South Korea Chronic Obstructive Pulmonary Disease (COPD) Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.
Strategic Points Covered in Table of Content of Global South Korea Chronic Obstructive Pulmonary Disease (COPD) Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the South Korea Chronic Obstructive Pulmonary Disease (COPD) market
Chapter 2: Exclusive Summary - the basic information of the South Korea Chronic Obstructive Pulmonary Disease (COPD) Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the South Korea Chronic Obstructive Pulmonary Disease (COPD)
Chapter 4: Presenting the South Korea Chronic Obstructive Pulmonary Disease (COPD) Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the South Korea Chronic Obstructive Pulmonary Disease (COPD) market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ www.prudentmarkets.com/enquiry-request/141681/
Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.
Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.
Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.
In conclusion, the South Korea Chronic Obstructive Pulmonary Disease (COPD) Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.
Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: [email protected]
Web: www.prudentmarkets.com
About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.
This release was published on openPR.
